Recessive Intermediate A Charcot-Marie-Tooth Disease

mutation in GDAP1

Also Known As:

Charcot-Marie-Tooth Disease, Recessive Intermediate A; CMTRIA; Charcot-Marie-Tooth Neuropathy, Recessive Intermediate A

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Type 4A Charcot-Marie-Tooth disease
2.	Type 2K Charcot-Marie-Tooth disease

1.	Covaleski, Anna Paula Paranhos Miranda: 1 article (01/2021)
2.	Figueiredo, Fernanda Barbosa: 1 article (01/2021)
3.	Giuliatti, Silvana: 1 article (01/2021)
4.	Gouvêa, Silmara de Paula: 1 article (01/2021)
5.	Hallak, Jaime E: 1 article (01/2021)
6.	Lourenço, Charles Marques: 1 article (01/2021)
7.	Marques, Wilson: 1 article (01/2021)
8.	Silva, Wilson Araújo: 1 article (01/2021)
9.	Tomaselli, Pedro José: 1 article (01/2021)

Drugs and Important Biological Agents (IBA) related to Recessive Intermediate A Charcot-Marie-Tooth Disease:

1.	GDAP proteinIBA 01/01/2021 - "Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) are associated with several subtypes of Charcot-Marie-Tooth (CMT) disease, including autosomal recessive and demyelinating (CMT4A); autosomal recessive and axonal (AR-CMT2K); autosomal dominant and axonal (CMT2K); and an intermediate and recessive form (CMTRIA). "